XBiotech Inc

XBITNASDAQ • USD
2.01 USD
↗ 0.05 (2.50%)🟢PRE MARKET (AS OF 07:01 AM EST)
🟢Market: OPEN

Shares of XBiotech Inc (XBIT) are trading at $2.01. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, XBIT appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$1.95
High?$2.01
Low?$1.95
Prev. Close?$1.96
Volume?0
Avg. Volume?79.9K
Bid / Ask
Bid?$1.57 × 100
Ask?$2.27 × 100
Spread?$0.70
Midpoint?$1.92
Valuation & Ratios
Market Cap?59.8M
Shares Out?30.5M
Float?16.6M
Float %?54.3%
P/E Ratio?N/A
P/B Ratio?0.47
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Employees
87
Market Cap
59.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-04-15
Address
5217 WINNEBAGO LANE
AUSTIN, TX 78744
Phone: 512-386-2900
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
98
Momentum?
23
Short Sent.?
84
Piotroski F-Score?0/9Weak
Altman Z-Score?5.13Safe
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.90%Low
Short Interest?315.3K
Days to Cover?2.6
Free Float16.6M
Avg Daily Volume119.2K
Settlement Date2026-10-30
Financial Health
Current Ratio?33.15Strong
Quick Ratio?33.15Strong
Cash Ratio?32.67Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.47CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
1.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
5
-35.1%WEAK▾
ROA?
S&P
3
-33.8%WEAK▾
Cash Flow & Enterprise
FCF?$-40839000
Enterprise Value?$-49772047
Fundamentals ratios updated end of day